Miravitlles M - Search Results

1

[Variability of antibiotic prescribing for respiratory tract infections in two European countries].

Llor C, Cots JM, Boada A, Bjerrum L, Gahrn-Hansen B, Munck A, Forés D, Miravitlles M; Grupo de Estudio AUDITINF02. Llor C, et al. Among authors: miravitlles m. Enferm Infecc Microbiol Clin. 2005 Dec;23(10):598-604. doi: 10.1157/13081568. Enferm Infecc Microbiol Clin. 2005. PMID: 16324549 Spanish.

2

[Use of the Internet in a multicenter study of chronic obstructive pulmonary disease in primary care. Pilot phase of the EFEMAP study].

Miravitlles M, Llor C, Naberan K, Cots JM; Estudio EFEMAP. Miravitlles M, et al. Arch Bronconeumol. 2002 Sep;38(9):427-30. doi: 10.1016/s0300-2896(02)75256-3. Arch Bronconeumol. 2002. PMID: 12237014 Spanish.

3

Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care.

Llor C, Naberan K, Cots JM, Molina J, Miravitlles M. Llor C, et al. Among authors: miravitlles m. Int J Clin Pract. 2004 Oct;58(10):937-44. doi: 10.1111/j.1368-5031.2004.00293.x. Int J Clin Pract. 2004. PMID: 15587773

4

Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.

Miravitlles M, Llor C, Naberan K, Cots JM, Molina J; EFEMAP study group. Miravitlles M, et al. Respir Med. 2005 Aug;99(8):955-65. doi: 10.1016/j.rmed.2005.01.013. Respir Med. 2005. PMID: 15950136 Free article. Clinical Trial.

5

[Risk factors for increased cost of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease].

Llor C, Naberan K, Cots JM, Molina J, Ros F, Miravitlles M; Estudio EFEMAP. Llor C, et al. Among authors: miravitlles m. Arch Bronconeumol. 2006 Apr;42(4):175-82. doi: 10.1016/s1579-2129(06)60439-4. Arch Bronconeumol. 2006. PMID: 16735014 Spanish.

6

Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting.

Miravitlles M, Llor C. Miravitlles M, et al. Clin Drug Investig. 2007;27(2):95-104. doi: 10.2165/00044011-200727020-00002. Clin Drug Investig. 2007. PMID: 17217314

7

More evidence is required for short-term treatment of exacerbations of chronic obstructive pulmonary disease: 3 days or no antibiotic at all?

Llor C, Miravitlles M. Llor C, et al. Among authors: miravitlles m. Clin Microbiol Infect. 2007 Jul;13(7):748-9. doi: 10.1111/j.1469-0691.2007.01754.x. Clin Microbiol Infect. 2007. PMID: 17501972 Free article. No abstract available.

8

Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare.

Llor C, Molina J, Naberan K, Cots JM, Ros F, Miravitlles M; EVOCA study group. Llor C, et al. Among authors: miravitlles m. Int J Clin Pract. 2008 Apr;62(4):585-92. doi: 10.1111/j.1742-1241.2008.01707.x. Epub 2008 Feb 7. Int J Clin Pract. 2008. PMID: 18266710

9

Factors determining the quality of life of patients with COPD in primary care.

Miravitlles M, Molina J, Naberan K, Cots JM, Ros F, Llor C; EVOCA study. Miravitlles M, et al. Ther Adv Respir Dis. 2007 Dec;1(2):85-92. doi: 10.1177/1753465807086097. Ther Adv Respir Dis. 2007. PMID: 19124350 Free article.

10

Validation of the COPD severity score for use in primary care: the NEREA study.

Miravitlles M, Llor C, de Castellar R, Izquierdo I, Baró E, Donado E. Miravitlles M, et al. Eur Respir J. 2009 Mar;33(3):519-27. doi: 10.1183/09031936.00087208. Epub 2009 Jan 22. Eur Respir J. 2009. PMID: 19164354 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

672 results

Search Page

Filters